Christelle Ferra
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Adverse Social Determinants Independently Predict Outcomes After Allogeneic HSCT.
Journal: Transplantation and cellular therapy
Published: January 08, 2026
Corrigendum to: "Combining three different pre-transplant scores improves predictive value in patients after haploidentical stem cell transplantation with TBF conditioning and PTCy" Journal: Transplant Cell Ther. 2021 Jul;27(7):614.e1-614.e8 doi: 10.1016/j.jtct.2021.03.021.
Journal: Transplantation and cellular therapy
Published: July 07, 2025
Corrigendum to: "Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF" Journal: Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027.
Journal: Transplantation and cellular therapy
Published: June 14, 2025
Genomic characterization of clonal B-cell lymphocytosis of marginal zone origin with MYC rearrangements.
Journal: Virchows Archiv : an international journal of pathology
Published: April 30, 2025
Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.
Journal: Bone marrow transplantation
Published: June 16, 2024
Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic?
Journal: Bone marrow transplantation
Published: May 28, 2024
Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors + Mycophenolate Mofetil versus Sirolimus + Mycophenolate Mofetil.
Journal: Transplantation and cellular therapy
Published: May 10, 2024
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group.
Journal: Leukemia
Published: April 03, 2024
Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC).
Journal: EClinicalMedicine
Published: January 12, 2024
Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience.
Journal: Medicina clinica
Published: May 16, 2023
Correction: Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Journal: Bone marrow transplantation
Published: April 19, 2023
Last Updated: 09/26/2026